Litigation Star, Top 100 Trial Lawyer, National Practice Area Star (Securities)
Benchmark Litigation 2026
"Jamie's calm and reasoned demeanor helps to depersonalize conflict and focus the parties on solutions."
Chambers USA 2025
“I really like working with Jamie. I find her to be smart, effective, aggressive and knowledgeable.”
Chambers USA 2025
"Outstanding trial lawyer...She is a go-to lawyer on 'bet the company' and other significant civil litigation."
Legal 500 US 2025
Ranked – Litigation: General Commercial
Chambers USA 2023-2025
Ranked – Litigation: Securities
Chambers USA 2018-2025
Top 100 Trial Lawyer
Benchmark Litigation 2021-2025
Top 250 Women in Litigation
Benchmark Litigation 2020-2025
Leading 500 Lawyers in America
Lawdragon 2017-2025
Leading Partner – General Commercial
Legal 500 US 2021-2025
Profile
Jamie Wine is one of the nation’s leading trial lawyers and a Fellow in the American College of Trial Lawyers. Her recent wins include a trial victory in Delaware Chancery Court for Scilex Pharmaceuticals in a breach of fiduciary duty and misappropriation of trades secret case, prevailing in an arbitration for John Paul Mitchell Systems in a several hundred million dollar dispute over an exclusive supply agreement with its primary contract manufacturer, the dismissal of a highly-publicized defamation suit against Chess.com relating to a grandmaster cheating scandal, and winning US$666 million in a post M&A dispute for DXC Technology Corporation.
In addition to her trial practice, Jamie regularly advises a number of public companies, the Big Four accounting firms, and various financial institutions on a variety of complex commercial and securities litigation matters, as well as SEC and other regulatory investigations.
Jamie is widely recognized for her excellence. She has been praised by leading publications and was a finalist for The American Lawyer’s Litigator of the Year (2020). She is consistently featured as a leading litigator and trial lawyer by Chambers USA, Legal 500, Benchmark Litigation and Lawdragon.
Jamie formerly served as Global Chair of Latham’s Litigation & Trial Department and prior to that as a member of the firm’s Executive Committee.
Experience
Jamie's experience includes:
Lead trial counsel for AIG Financial Products in a Delaware Bankruptcy Court adversary proceeding, in connection with its chapter 11 restructuring, regarding the treatment of debt related to pre-2008 financial crisis deferred compensation plans; decision pending
Prevailed as lead trial counsel for John Paul Mitchell Systems, defeating primary wrongful termination claim brought by a contract manufacturer under an exclusive supply agreement, and winning on multiple counterclaims for breaches of contract, with attorneys’ fees and costs awarded to JPMS
Won complete dismissal, on a motion to dismiss, of a securities class action filed in the Northern District of California against Akero Therapeutics and certain of its officers and directors, alleging that the defendants had misled investors about the design of a clinical trial testing a pioneering liver drug
Won complete dismissal, on a motion to dismiss, of a securities class action filed in the Eastern District of Virginia against DXC Technology Company and several of its officers relating to statements made about its merger integration plans
Won complete dismissal, on a motion to dismiss, of a RICO class action filed in the Southern District of New York against KPMG LLP alleging over $100 billion in potential damages
Won plaintiffs-side trial victory in the Delaware Court of Chancery for Sorrento Therapeutics and Scilex Pharmaceuticals in breach of fiduciary duty, breach of contract, and misappropriation of trade secrets case
Won dismissal of defamation and antitrust claims against Chess.com in highly-publicized chess grandmaster cheating scandal
Won US$125 million as lead trial counsel for Sorrento Therapeutics in a breach of contract case over the failed development efforts of a Phase III cancer drug
Successfully resolved securities class action claims against Covetrus and its senior officers, and obtained voluntary dismissal of stockholder derivative claims against board of directors
Won complete victory as lead trial counsel in a post M&A dispute for a Fortune 500 company defeating US$1 billion claim and winning US$70 million counterclaim
Won US$666 million as lead trial counsel for DXC Technology Company against Hewlett Packard Enterprise Company in a post-M&A dispute
Won dismissal of stockholder derivative claims and related federal securities class action lawsuits against DXC Technology Company and its directors and officers related to DXC’s formation
Won a high-profile summary judgment victory for the US Soccer Federation as lead trial counsel in its litigation with the US Senior Women’s National Team regarding equal pay
Won complete dismissal, on a motion to dismiss, for Booz Allen in a securities class action in the SDNY related to the sale of its government business to The Carlyle Group; also acted as lead trial counsel in a related individual securities fraud suit, which resolved with a favorable settlement during trial
Won complete defense victory as lead trial counsel in an arbitration for a Big Four accounting firm brought by the Trustee of its former audit client
Won complete dismissal, on a motion to dismiss and affirmed on appeal, for Ferrellgas, Inc. in a securities class action in the SDNY relating to statements about a corporate acquisition and the effect of declining crude oil prices on the business
Won complete dismissal, on a motion to dismiss, for Aratana Therapeutics, Inc. in a securities class action in the SDNY relating to the timing and release of a new FDA-approved drug
Won complete dismissal, on a motion to dismiss, for Pacira Pharmaceuticals, Inc. in a securities class action in the District of New Jersey relating to statements about product safety and efficacy
Reached favorable settlement for HCA, Inc. in a securities class action in the District of Tennessee alleging omission of purported revenue trends in IPO offering materials
Won complete defense victory for Ernst & Young as lead trial counsel in an arbitration brought by the Lehman Creditors Committee, and won dismissal of all Section 11 and most Section 10b claims in the Lehman multi-district shareholder litigation in the SDNY
Represented Deutsche Bank in numerous federal and state actions across the US related to RMBS
Lead trial counsel in successful arbitration of a multi-million dollar confidential tax shelter matter for a Big Four accounting firm
Won complete trial victory, confirmed on appeal, for a KPMG audit partner in an SEC proceeding alleging improper professional conduct related to Royal Ahold
Won complete dismissal, on summary judgment and affirmed on appeal, for Caesars Bahamas Investment Corp. (Harrah’s) in a dispute regarding the multi-billion dollar Baha Mar casino resort project
Won complete dismissal, on summary judgment, in one class action and reached favorable settlement in the other for Ernst & Young relating to its audits of The Williams Companies
Won complete dismissal for PricewaterhouseCoopers on summary judgment, affirmed on appeal, in a securities class action relating to its audits of Chantal Pharmaceuticals
A Latham Securities and M&A Litigation team secured a Second Circuit affirmance of their prior dismissal on behalf of KPMG, in a major shareholder class action stemming from the collapse of Credit Suisse with alleged damages exceeding US$120 billion.
Firm’s restructuring and Litigation & Trial team advises on the technology-enabled healthcare services company’s chapter 11 process to strengthen its future, reduce debt, and inject capital.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.